← FDA Drug Approvals (Drugs@FDA)

BREXAFEMME

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2021-06-01

Drug application

FDA Application #

NDA214900

Application type

New Drug Application

Brand name

BREXAFEMME

Generic name

Ibrexafungerp Citrate

Active ingredients

IBREXAFUNGERP CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

First approval

2021-06-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown